How to capture the gene- editing and therapy market? In my view, one company offers a unique opportunity to play the immense growth within the field - the American company MaxCyte $MXCT, listen on London AIM
MaxCyte sells its ExPERT machine and platform to cell therapy and drug discovery companies. They have 120+ cell therapy partner programs with 90+ being licensed for clinical use and 20 out of the 25 largest pharma companies are their customers within drug-discovery.